Cargando…
Prognostic indicators for gastrointestinal stromal tumors: a review
Gastrointestinal stromal tumors (GISTs) are potentially malignancies that can occur anywhere in the digestive tract. Tyrosine kinase inhibitors (TKIs) such as imatinib have proven effective since the discovery of KIT and PDGFRA. The current version of NCNN, ESMO and EURACAN guidelines recognized tha...
Autores principales: | Zhang, Haixin, Liu, Qi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327422/ https://www.ncbi.nlm.nih.gov/pubmed/32619820 http://dx.doi.org/10.1016/j.tranon.2020.100812 |
Ejemplares similares
-
Gastrointestinal Stromal Tumor and Ki-67 as a Prognostic Indicator
por: Kadado, Kevin J, et al.
Publicado: (2022) -
Management of hemorrhage in gastrointestinal stromal tumors: a review
por: Liu, Qi, et al.
Publicado: (2018) -
Current management and prognostic features for gastrointestinal stromal tumor (GIST)
por: Lamba, Gurpreet, et al.
Publicado: (2012) -
Prognostic Analysis of Duodenal Gastrointestinal Stromal Tumors
por: Hong, Liwen, et al.
Publicado: (2018) -
Gastrointestinal stromal tumor
por: Stamatakos, Michael, et al.
Publicado: (2009)